Luspatercept, sold under the brand name Reblozyl, is a medication used for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. The US Food and Drug Administration considers it to be a first-in-class medication. From Wikipedia
The pharmaceutical giant's strong performance is driven by robust sales of Eliquis and new growth drugs.
